CTOs on the Move

Sinaiko Healthcare Consulting

www.sinaikohc.com

 
Sinaiko Healthcare Consulting is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.sinaikohc.com
  • 1875 Century Park E Ste 2100
    Los Angeles, CA USA 90067
  • Phone: 310.551.5252

Executives

Name Title Contact Details

Similar Companies

Governance Institute, The

Governance Institute, The is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ClearMedical

ClearMedical Inc. is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tykes and Teens

Tykes & Teens was established in 1996 with the goal of strengthening local families by ensuring that all children have access to high quality counseling and mental health services, regardless of financial status. The agency provides a comprehensive range of programming in Martin, St. Lucie, Indian River and Okeechobee counties.

Bioatla

BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.